首页> 外国专利> COMPOSITE FORMULATION OF DUTASTERIDE AND TADALAFIL COMPRISING GLYCEROL FATTY ACID ESTER DERIVATIVE OR PROPYLENE GLYCOL FATTY ACID ESTER DERIVATIVE AND ORAL CAPSULE FORMULATION COMPRISING THE SAME

COMPOSITE FORMULATION OF DUTASTERIDE AND TADALAFIL COMPRISING GLYCEROL FATTY ACID ESTER DERIVATIVE OR PROPYLENE GLYCOL FATTY ACID ESTER DERIVATIVE AND ORAL CAPSULE FORMULATION COMPRISING THE SAME

机译:包含甘油脂肪酸酯衍生物或丙二醇脂肪酸酯衍生物和口服胶囊制剂的硬脂酸酯和他达那非的复合制剂

摘要

The present invention is related to a composite formulation of dutasteride and tadalafil, therapeutic agents for prostatic hyperplasia, and to an oral capsule preparation containing the same. The composite formulation has the total amount of the composition inside a capsule of 400 mg or less so that the size of the capsule is convenient for the patient to take so as to increase patients' convenience, and includes a glycerol fatty acid ester derivative or a propylene glycol fatty acid ester derivative which may increase the solubility of dutasteride, a poorly soluble medicament and improve the stability of tadalafil so as to dissolve dutasteride and disperse tadalafil.
机译:本发明涉及度他雄胺和他达拉非的复合制剂,用于前列腺增生的治疗剂以及包含它们的口服胶囊制剂。该复合制剂在胶囊内的组合物总量为400mg或更小,以使胶囊的大小便于患者服用以增加患者的便利性,并且包括甘油脂肪酸酯衍生物或甘油酯。丙二醇脂肪酸酯衍生物,可以增加度他雄胺的溶解度,这是一种难溶药物,并提高他达拉非的稳定性,从而溶解度他雄胺并分散他达拉非。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号